Recent News

• 03.18.2026 - Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results

Recent Filings

• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.17.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.29.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors